Skip to main content
Top
Published in: European Journal of Orthopaedic Surgery & Traumatology 6/2018

01-08-2018 | Original Article • SPINE - METASTASES

Preoperative embolization and local hemostatic agents in palliative decompression surgery for spinal metastases of renal cell carcinoma

Authors: Nikita Zaborovskii, Dmitrii Ptashnikov, Dmitrii Mikaylov, Sergei Masevnin, Oleg Smekalenkov

Published in: European Journal of Orthopaedic Surgery & Traumatology | Issue 6/2018

Login to get access

Abstract

Background

Intraoperative hemorrhage can sometimes be massive in patients with spinal metastasis of renal cell carcinoma (MRCC). Preoperative embolization and local hemostatic agents are routinely use in spinal tumor surgery, but there have been no comparisons between these methods. This report compares the efficiency of various methods of bleeding control and their influence on outcome and survival after decompression procedures for MRCC.

Materials and methods

This was a retrospective case–control study of 54 patients with hypervascular extraosseous MRCC. All patients underwent palliative decompression procedures. We compared two groups of patients stratified by methods of bleeding control. The first group (EMB) included 32 patients who underwent preoperative embolization of a tumor. The second group (HEM) consisted of 22 patients, treated surgically using intraoperative local hemostatic agents. The parameters under evaluation were blood loss volume, drainage loss, possible complications, time of hospital stay and survival.

Results

The median intraoperative blood loss for EMB group [1275 (95% CI 1175–1500) mL] was slightly less than the median in HEM group [1400 (95% CI 1050–1725) mL] without significant differences (p = 0.681). The postoperative drainage loss in HEM group [250 (95% CI 140–325) mL] was significantly less than that in EMB group [500 (95% CI 425–550) mL] (p = 0.013). The complication rate (infections, hematomas, neurological deficit) was nearly equal in all groups. No statistically significant difference in overall survival was found between groups: EMB—26 months (1 year—93.3%, 3 years—26.7%) and HEM—24 months (1 year—95.2%, 3 years—16.3%) (p = 0.360).

Conclusion

Our results suggest that not all patients with MRCC require preoperative embolization, because usage of modern hemostatic agents can be an alternative bleeding control method.
Literature
7.
go back to reference Renkens KL, Payner TD, Leipzig TJ et al (2001) A multicenter, prospective, randomized trial evaluating a new hemostatic agent for spinal surgery. Spine (Phila Pa 1976) 26:1645–1650CrossRef Renkens KL, Payner TD, Leipzig TJ et al (2001) A multicenter, prospective, randomized trial evaluating a new hemostatic agent for spinal surgery. Spine (Phila Pa 1976) 26:1645–1650CrossRef
23.
go back to reference Jackson R, Gokaslan Z, Arvinloh S (2001) Metastatic renal cell carcinoma of the spine: surgical treatment and results. J Neurosurg Spine 1:18CrossRef Jackson R, Gokaslan Z, Arvinloh S (2001) Metastatic renal cell carcinoma of the spine: surgical treatment and results. J Neurosurg Spine 1:18CrossRef
25.
go back to reference Quraishi N, Purushothamdas S, Manoharan S (2013) Outcome of embolised vascular metastatic renal cell tumours causing spinal cord compression. Eur Spine 22:27–32CrossRef Quraishi N, Purushothamdas S, Manoharan S (2013) Outcome of embolised vascular metastatic renal cell tumours causing spinal cord compression. Eur Spine 22:27–32CrossRef
Metadata
Title
Preoperative embolization and local hemostatic agents in palliative decompression surgery for spinal metastases of renal cell carcinoma
Authors
Nikita Zaborovskii
Dmitrii Ptashnikov
Dmitrii Mikaylov
Sergei Masevnin
Oleg Smekalenkov
Publication date
01-08-2018
Publisher
Springer Paris
Published in
European Journal of Orthopaedic Surgery & Traumatology / Issue 6/2018
Print ISSN: 1633-8065
Electronic ISSN: 1432-1068
DOI
https://doi.org/10.1007/s00590-018-2162-6

Other articles of this Issue 6/2018

European Journal of Orthopaedic Surgery & Traumatology 6/2018 Go to the issue